Depo-Provera Lawsuit Sign Ups Expected To Continue as First Brain Tumor Cases Prepared for Trial

While lawyers prepare for a series of early pilot trials, claims for thousands of women are still being reviewed to confirm whether their meningioma diagnosis may be eligible for financial compensation.

Women throughout the U.S. are continuing to seek information on how to sign up for the Depo-Provera lawsuit, as lawyers work to prepare a group of pilot test cases for trial, to see how juries will respond to evidence that links the popular birth control shot to over a five-fold increased risk of meningioma tumors.

Since the first complaint was filed in October 2024, nearly 300 Depo-Provera meningioma lawsuits have already been brought by former users of the birth control shot, each raising similar allegations that long-term use of Depo-Provera caused the development of intracranial tumors. Plaintiffs maintain that Pfizer and certain other generic manufacturers failed to adequately warn women and the medical community about these risks.

In response to the growing number of lawsuits, the U.S. Judicial Panel on Multidistrict Litigation (JPML) centralized all federal Depo-Provera claims in February 2025, assigning the litigation to U.S. District Judge M. Casey Rodgers in the Northern District of Florida for coordinated discovery and streamlined pretrial proceedings.

Within days of her appointment, Judge Rodgers independently selected five bellwether cases for lawyers to prepare for early trial dates, and she is continuing to hold monthly case management conferences throughout 2025.

As the litigation moves forward at a quick pace, the number of claims continues to rise and many women are just now learning that their meningioma may have been caused by Depo-Provera. Therefore, the size of the litigation is expected to grow dramatically at the same time the first cases are being prepared for trial.

In this featured post, AboutLawsuits.com outlines what you need to know to sign up for the Depo-Provera brain tumor lawsuit, including:

• Which types of meningiomas qualify
• How to determine your tumor type
• Which brands of Depo-Provera are included
• What medical records are needed to get started
• How long you have to file your claim
• How to sign up for a Depo-Provera meningioma lawsuit

If you have been diagnosed with a brain tumor after receiving Depo-Provera, you may be entitled to compensation. Free Depo-Provera lawsuit consultations are now being offered by attorneys investigating claims nationwide.

📋 Brain Tumors That Qualify for Depo-Provera Lawsuits

All of the qualifying tumors in the Depo-Provera litigation fall under the category of meningioma, which forms in the lining of the brain and spinal cord (the meninges). While many meningiomas are non-cancerous, they can grow large, become symptomatic, and lead to serious health complications.

To help individuals understand whether they may qualify, these tumors are typically described in two different ways:

• By location: Refers to where in the brain the tumor is growing. These names often appear in radiology or imaging reports, such as an MRI or CT scan.
• By subtype: Refers to the tumor’s cellular makeup. These names usually appear in pathology reports if the tumor was biopsied or removed surgically.

Both classification types are included in the litigation, and you may qualify if your tumor was described using either kind of terminology.

▶️ Meningioma Types by Location

These tumor names are based on where the growth occurs in the brain:

• Convexity Meningioma: These tumors form on the outer surface of the brain. Symptoms often include headaches, seizures or weakness in the arms or legs.
• Parasagittal Meningioma: Located near the midline of the brain, these tumors may cause leg weakness, balance issues or loss of bladder control.
• Falcine Meningioma: Develops along the falx cerebri, which divides the brain’s hemispheres. Symptoms may include personality changes, speech problems or motor difficulties.
• Sphenoid Wing Meningioma: Found near the base of the skull around the eye sockets. Symptoms often involve blurred vision, double vision or facial numbness.
• Olfactory Groove Meningioma: Located at the front base of the skull near the nose. These may cause loss of smell, confusion or behavior changes.
• Posterior Fossa / Petrous Meningioma: Found near the brainstem and cerebellum. Symptoms can include dizziness, hearing loss or coordination problems.
• Foramen Magnum Meningioma: Forms where the brain connects to the spinal cord. These can cause neck pain, arm weakness or difficulty swallowing.
• Suprasellar Meningioma: Grows near the optic nerves and pituitary gland. Symptoms often include vision problems, hormonal changes or fatigue.
• Intraventricular Meningioma: These form inside the brain’s fluid-filled ventricles. Symptoms typically include headaches, confusion, nausea or signs of fluid buildup.

▶️ Meningioma Types by Subtype (Histology)

These terms describe the cellular structure of the tumor and are usually found in biopsy or surgical pathology reports:

• Meningothelial Meningioma: The most common subtype, often slow-growing and benign. Symptoms vary depending on the tumor’s location in the brain.
• Fibrous (Fibroblastic) Meningioma: Composed of dense connective tissue. These may grow slowly and present with pressure-related symptoms.
• Psammomatous Meningioma: Characterized by calcium deposits called psammoma bodies. These tumors are often asymptomatic unless they grow large.
• Angiomatous Meningioma: Rich in blood vessels and may lead to brain swelling or bleeding. Symptoms can include headaches, seizures or neurological deficits.
• Secretory Meningioma: A rare subtype that can retain fluid and cause swelling. These tumors may lead to brain edema and neurological impairment.

If you are not sure what type of meningioma you were diagnosed with, the next section explains how to find out by checking your imaging or medical records.

🔍 How Do I Find Out Which Type of Meningioma I Have?

Many women who are eligible to file a Depo-Provera brain tumor lawsuit may not immediately know the exact type or location of their meningioma. Fortunately, this information is usually available in your medical records and can be confirmed during a free case evaluation.

Here are the best ways to find out what kind of meningioma you were diagnosed with:

1. Review Imaging Reports (MRI or CT Scans): When you were first diagnosed, your doctor likely ordered a brain MRI or CT scan. The radiology report will often include the location of the tumor, such as “convexity,” “skull base” or “parasagittal.” You can request a copy of this report from your hospital or imaging center.
2. Check Surgical or Pathology Records: If you had surgery or a biopsy, the pathology report will describe the tumor subtype—such as meningothelial, psammomatous or angiomatous meningioma. These reports are typically available from the neurosurgeon or hospital where your procedure was performed.
3. Ask Your Treating Doctor or Specialist: Your neurologist, neurosurgeon or oncologist may have already explained your tumor type during treatment. If you are unsure, you can call their office and request documentation or a written diagnosis summary.
4. Let an Attorney Help Retrieve Records: If you are unable to locate your records, lawyers handling Depo-Provera lawsuits can assist. With your permission, they can request and review your medical records to determine whether you meet the criteria outlined in the federal court order.

You do not need to know your tumor type before reaching out to a lawyer. A free case review can help you get the answers you need and determine whether you qualify for a claim.

💉 Which Depo-Provera Injections Qualify for Brain Tumor Lawsuits?

Not all injectable birth control products are included in the current lawsuits. To qualify for a Depo-Provera brain tumor claim, your injections must have contained medroxyprogesterone acetate (MPA)—a synthetic hormone that has been linked to an increased risk of meningioma.

The litigation is focused on specific manufacturers of the brand name birth control shot, and authorized generic versions sold by certain pharmaceutical companies, including:

• Depo-Provera: The brand-name intramuscular injection originally manufactured by Pfizer.
• Depo-Provera IM / DMPA / Depot Medroxyprogesterone Acetate: Common references to the standard intramuscular formulation.
• Depo-SubQ Provera 104: A lower-dose, subcutaneous version of the birth control shot.
• Greenstone Medroxyprogesterone / Greenstone MPA: Generic versions distributed by Greenstone, a Pfizer-owned company.
• Prasco Medroxyprogesterone / Prasco MPA: Generic formulations distributed by Prasco Laboratories.
• DPCI / IM MPA: Alternate medical or pharmacy abbreviations for medroxyprogesterone acetate injections.

If you received any of these injections before being diagnosed with a brain tumor, you may qualify to pursue compensation—even if the shots were given many years ago or under different brand names.

🔍 How Do I Find Out Which Type of Depo-Provera I Received?

If you’re not sure which version of Depo-Provera you were given, you’re not alone. Many women don’t know whether they received the brand-name or a generic equivalent, especially if they were given routine injections over many years.

Here’s how you can find out:

• Contact Your OB/GYN or Primary Care Provider: Your doctor’s office can typically provide a record of the exact Depo injection you received. This may be listed in your visit summaries, electronic chart or prescription history.
• Review Your Insurance Records: Health insurers often list the medication name and billing code on Explanation of Benefits (EOB) forms.
• Let a Lawyer Help: Attorneys handling Depo-Provera claims can obtain these records for you, with your permission, as part of the free case evaluation process.

❗ Important Note: You do not need to know the exact formulation of Depo-Provera you received in order to sign up for a case review. If you’re unsure, it’s completely appropriate to contact your doctor or pharmacist for clarification.

Keep in mind that medical providers were never warned by the manufacturer about the potential risk of brain tumors from these injections, so many were unaware of the connection themselves. These are common and reasonable questions, and most healthcare professionals can quickly access your records and provide the information you need.

🗂️ What Information Will a Lawyer Need To Evaluate My Case?

After learning which tumors and injections qualify for a Depo-Provera lawsuit, the next step is understanding what information will be used to evaluate your claim. Fortunately, you do not need to have all your records on hand to begin. Most law firms handling these cases will help gather your records as part of the free case evaluation process.

Here is what attorneys typically look for:

Diagnosis Information:

• MRI or CT scan reports
• Pathology results (if surgery or biopsy was performed)
• Physician notes confirming your meningioma diagnosis

Injection History:

• Pharmacy logs or prescription history
• Insurance billing codes for birth control injections
• OB/GYN records showing Depo-Provera use

📅 How Long Do I Have To Sign Up for a Depo-Provera Brain Tumor Lawsuit?

Once your eligibility is clear, timing becomes critical. Each state has its own statute of limitations, which sets a legal deadline for how long you have to file a product liability lawsuit. In most states, this window ranges from one to six years, but determining when this period of time begins running can be complex.

When it comes to injuries caused by medications like Depo-Provera, the clock often doesn’t start until you learn—or reasonably should have learned—that the drug may have caused your injury. This legal concept is known as the “discovery rule,” and it plays an important role in cases where critical health risks were not disclosed at the time of treatment.

In the case of Depo-Provera:

• Women in the U.S. were never warned about the risk of meningioma.
• No public safety alert was issued by the FDA.
• No updated warning has been added to the Depo-Provera label in the United States, despite growing research and international action.

As a result, most consumers only became aware of the potential link between their brain tumor and Depo-Provera within the past six months, following the release of new research and the growing number of lawsuits filed, or after consulting with a medical or legal professional.

❗ Important Note: This means that even if your diagnosis occurred years ago, you may still be eligible to file a claim if you only recently learned about the potential connection between Depo-Provera and meningioma side effects.

⚖️ How to Sign Up for a Depo-Provera Brain Tumor Lawsuit

If you’ve been diagnosed with a qualifying type of brain tumor after receiving Depo-Provera injections, signing up for a lawsuit is straightforward—and there is no cost to get started.

Every case begins with a free consultation with an experienced product liability attorney. During this review, a Depo-Provera lawyer will help confirm your eligibility by evaluating your diagnosis, injection history and timeline. Even if you are unsure which type of meningioma you had or which formulation of Depo-Provera you received, attorneys can assist in gathering the records needed to support your claim.

You can begin the process by filling out the form below to submit your information. If your case qualifies, you may be entitled to compensation for:

• Medical expenses and long-term care
• Lost wages or reduced earning potential
• Physical and emotional suffering caused by the tumor or treatment
• The cost of future monitoring or neurological care

There are no fees or expenses unless you win. Lawyers handling Depo-Provera lawsuits work on a contingency basis, so there’s no financial risk in finding out whether you qualify.

Time limits apply to every claim, and early action may lead to more favorable options as the litigation progresses.